Blood Disorder Research

Mercy Research studies examine the diagnosis, treatment, prognosis and prevention of diseases and conditions related to Blood Disorders (Hematology).

Studies include: anemia, bleeding disorders, blood-clotting disorders, leukemia, platelet disorders, red-cell disorders, lymphoma, vitamin deficiencies and white-cell disorders.

Community Project Title Study Details Sponsor Contact Study Site

Chronic Immune Thrombocytopenia

Oklahoma City Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura) Learn more Eisai Mercy Clinic Oncology and Hematolgy McAuley

Chronic Lymphocytic Leukemia

Oklahoma City Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, and Ibrutinib Alone in Treating Older Patients with Previously Untreated Chronic Lymphocytic Leukemia Learn more National Cancer Institute Mercy Clinic Oncology and Hematolgy McAuley
Springfield A phase III, open label, randomized, multicenter trial of ofatumumab maintenance treatment versus no further treatment in subjects with relapsed chronic lymphocytic leukemia (CLL) who have responded to induction therapy Learn More GlaxoSmithKline Mercy Medical Research Institute - Smith Glynn Callaway
Springfield An Open-Label, Multicenter, Phase Ib Trial of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia Learn more Genentech Mercy Medical Research Institute - Smith Glynn Callaway
St. Louis 10-051 - Connect CLL: The Chronic Lymphocytic Leukemia Disease Registry Learn more Celgene Corporation Mercy Oncology Research-David C Pratt Cancer Center

Chronic Myelomonocytic Leukemia and MDS

Oklahoma City Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Learn more Southwest Oncology Group Mercy Clinic Oncology and Hematolgy McAuley

Gout

Washington Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment Learn more Takeda Mercy Health Research Washington
Washington Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout Learn more Takeda Mercy Health Research Washington

Leukemia or Refractory Solid Tumors

St. Louis MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Learn More Children's Oncology Group  Mercy Oncology Research-David C Pratt Cancer Center

Lung Cancer

Oklahoma City Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB/IV Squamous Cell Non-small Cell Lung Cancer (aboundsqm) Learn more Celgene Mercy Clinic Oncology and Hematolgy McAuley

Multiple Myeloma

Oklahoma City Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma Learn more Amgen Mercy Clinic Oncology and Hematolgy McAuley
St. Louis Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (OPTIMISMM) Learn more Celgene Corporation Mercy Oncology Research-David C Pratt Cancer Center
St. Louis Connect® MM- The Multiple Myeloma Disease Registry Learn more Celgene Corporation Mercy Oncology Research-David C Pratt Cancer Center
Fort Smith Connect® MM- The Multiple Myeloma Disease Registry Learn more Celgene Corporation Mercy Medical Research - Fort Smith

Myelodysplastic Syndrome

St. Louis A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide vs. Azacitidine vs. Azacitidine in Combination with Vorinostat for Higher-Risk MDS Learn more Southwest Oncology Group Mercy Oncology Research-David C Pratt Cancer Center

Non-Hodgkin's Lymphoma

St. Louis Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Learn more University of Chicago Mercy Oncology Research-David C Pratt Cancer Center
Oklahoma City Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma Learn more Pfizer Mercy Clinic Oncology and Hematolgy McAuley
Oklahoma City Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Learn more Cancer and Leukemia Group B Mercy Clinic Oncology and Hematolgy McAuley
Springfield A Multicentre, Phase III, Open Label, Randomized Study in Previously Untreated Patients With Advanced Indolent Non-Hodgkin's Lymphoma Evaluating the Benefit of GA101 (RO5072759) + Chemotherapy Compared to Rituximab + Chemotherapy Followed by GA101 or Rituximab Maintenance Therapy in Responders Learn more Hoffmann-La Roche Mercy Medical Research Institute - Smith Glynn Callaway

T-Cell Lymphoma

Oklahoma City ECHELON-2: A Comparison of Brentuximab Vedotin and CHP with Standard-of-care CHOP in the Treatment of Patients with CD30-positive Mature T-Cell Lymphomas Learn more Seattle Genetics Mercy Clinic Oncology and Hematolgy McAuley

 

Find Blood Disorder Research Services Near You

Top News

Food Allergy Research and Education (FARE) is encouraging communities to start a new tradition to...
Lifesaving Telestroke Program Connects Patients to Specialists for Quicker Treatment Closer to Home
Subscribe to Mercy News Coverage

Career Center see all